Vijayakumar K, Manoharan D, Subbarayan R, Shrestha R, Harshavardhan S
Mol Biol Rep. 2024; 51(1):934.
PMID: 39180671
DOI: 10.1007/s11033-024-09856-0.
Yolmo P, Rahimi S, Chenard S, Conseil G, Jenkins D, Sachdeva K
Cancer Immunol Res. 2024; 12(10):1320-1339.
PMID: 38916567
PMC: 11443217.
DOI: 10.1158/2326-6066.CIR-23-1114.
Vu G, Awad V, Norberto M, Bowman T, Trompouki E
Exp Hematol. 2023; 131:104148.
PMID: 38151171
PMC: 11061806.
DOI: 10.1016/j.exphem.2023.104148.
Wang Y, Zhou S, Wang Y, Lu Z, Zhang Y, Xu C
Nat Commun. 2023; 14(1):1993.
PMID: 37031188
PMC: 10082825.
DOI: 10.1038/s41467-023-37656-w.
Aditi , McKinnon P
DNA Repair (Amst). 2022; 119:103406.
PMID: 36148701
PMC: 9844216.
DOI: 10.1016/j.dnarep.2022.103406.
Transcriptomics reveals specific molecular mechanisms underlying transgenerational immunity in .
Roesel C, Rosengaus R, Smith W, Vollmer S
Ecol Evol. 2020; 10(20):11251-11261.
PMID: 33144962
PMC: 7593158.
DOI: 10.1002/ece3.6764.
Toll-Like Receptor 9 Agonists in Cancer.
Karapetyan L, Luke J, Davar D
Onco Targets Ther. 2020; 13:10039-10060.
PMID: 33116588
PMC: 7553670.
DOI: 10.2147/OTT.S247050.
Analysis of complete genomes identifies genomospecies features, secretion systems and novel plasmids and their association with severe ulcerative colitis.
Liu F, Chen S, Luu L, Lee S, Tay A, Wu R
Microb Genom. 2020; 6(11).
PMID: 33111662
PMC: 7725323.
DOI: 10.1099/mgen.0.000457.
TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma.
Roy Chattopadhyay N, Chatterjee K, Tiwari N, Chakrabarti S, Sahu S, Roy S
iScience. 2020; 23(3):100937.
PMID: 32179470
PMC: 7068130.
DOI: 10.1016/j.isci.2020.100937.
Formulation technologies for oral vaccines.
New R
Clin Exp Immunol. 2019; 198(2):153-169.
PMID: 31318446
PMC: 6797897.
DOI: 10.1111/cei.13352.
Cell-free synthesis of human toll-like receptor 9 (TLR9): Optimization of synthesis conditions and functional analysis.
Dondapati S, Pietruschka G, Thoring L, Wustenhagen D, Kubick S
PLoS One. 2019; 14(4):e0215897.
PMID: 31022289
PMC: 6483205.
DOI: 10.1371/journal.pone.0215897.
The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.
Tian S, Zhang L, Yang T, Wei X, Zhang L, Yu Y
Mediators Inflamm. 2018; 2018:9127146.
PMID: 30147445
PMC: 6083594.
DOI: 10.1155/2018/9127146.
Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.
Mohamed H, Chernajovsky Y, Gould D
Sci Rep. 2016; 6:29388.
PMID: 27387837
PMC: 4937410.
DOI: 10.1038/srep29388.
CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells.
Xing N, Qiao T, Zhuang X, Yuan S, Zhang Q, Xu G
Onco Targets Ther. 2015; 8:1443-9.
PMID: 26109868
PMC: 4472028.
DOI: 10.2147/OTT.S84467.
A proteomics perspective on viral DNA sensors in host defense and viral immune evasion mechanisms.
Crow M, Javitt A, Cristea I
J Mol Biol. 2015; 427(11):1995-2012.
PMID: 25728651
PMC: 4669196.
DOI: 10.1016/j.jmb.2015.02.016.
RNA:DNA hybrids are a novel molecular pattern sensed by TLR9.
Rigby R, Webb L, Mackenzie K, Li Y, Leitch A, Reijns M
EMBO J. 2014; 33(6):542-58.
PMID: 24514026
PMC: 3989650.
DOI: 10.1002/embj.201386117.
Traditional biochemical assays for studying toll-like receptor 9.
Leifer C, Rose 2nd W, Botelho F
J Immunoassay Immunochem. 2013; 34(1):1-15.
PMID: 23323977
PMC: 4451183.
DOI: 10.1080/15321819.2012.666222.
New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.
Wallace D, Gudsoorkar V, Weisman M, Venuturupalli S
Nat Rev Rheumatol. 2012; 8(9):522-33.
PMID: 22801982
DOI: 10.1038/nrrheum.2012.106.
DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature.
Li Y, Berke I, Modis Y
EMBO J. 2012; 31(4):919-31.
PMID: 22258621
PMC: 3280545.
DOI: 10.1038/emboj.2011.441.
Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
Durfort T, Tkach M, Meschaninova M, Rivas M, Elizalde P, Venyaminova A
PLoS One. 2012; 7(1):e29213.
PMID: 22235273
PMC: 3250415.
DOI: 10.1371/journal.pone.0029213.